600511 国药股份
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额(2,050,433)1,659,1202,726,6572,395,1231,957,451
投资活动产生之现金流量净额(7,875)(2,583,710)(129,311)(152,319)(122,991)
筹资活动产生之现金流量净额(1,076,081)(1,582,333)(632,176)(639,573)(745,962)
汇率变动对现金及现金等价物的影响----------
现金及现金等价物净增加/(减少)(3,134,388)(2,506,924)1,965,1701,603,2321,088,497
期初现金及现金等价物余额8,291,39410,798,3188,833,1487,229,9166,141,419
期末现金及现金等价物余额5,157,0068,291,39410,798,3188,833,1487,229,916